复发性/耐火性CLL和里希特转换的管理方面的进展
Nathalie Javidi-Sharifi1, Matthew S Davids1
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Hematological oncology
|June 15, 2025
概括
治疗复发性/耐药性慢性淋巴细胞白血病 (CLL) 和里希特转变 (RT) 是一个挑战. 本综述涵盖了这些难以治疗的血液癌症的新疗法和策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床治疗学 临床治疗学
背景情况:
- 复发性/耐药性 (R/R) 慢性淋巴细胞白血病 (CLL) 和里希特转变 (RT) 存在显著的未满足需求.
- 在共价布鲁顿氨酸激酶抑制剂 (BTKi) 和venetoclax后进展的患者面临着不良预后.
研究的目的:
- 审查R/R CLL和RT管理的最新进展.
- 讨论已批准的疗法,试验药物和高风险患者群体的组合策略.
主要方法:
- 对最近的临床试验和已批准的治疗方法的文献综述.
- 对R/RCLL和RT的新型治疗方法的数据综合.
- 讨论新兴的治疗药物,包括BTK降解剂和双特异性抗体.
主要成果:
- 非共价BTKi和CAR-T细胞为R/RCLL提供了新的治疗途径.
- 在临床试验中,BTK降解剂和双特异性抗体显示出早期的希望.
- 基于Venetoclax的组合可能会提高RT的完整反应率,但需要进一步优化.
结论:
- 新型治疗策略对于改善R/R CLL和RT的结果至关重要.
- 对实验药物和组合疗法的持续研究对于解决治疗挑战至关重要.
- 解决双耐火性CLL和RT需要创新的方法,超出目前的护理标准.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.5K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.5K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Bone Marrow Sampling and Transplants
509
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
509
